Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 10,000 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 26, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 7, 2024 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 30, 2023 | Aeglea BioTherapeutics, Inc. (AGLE) | Grant/Award | 1,950,000 | n/a |
| Jun 9, 2023 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 35,000 | n/a |
| Jul 15, 2022 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 30,000 | n/a |
| Jun 10, 2022 | Aeglea BioTherapeutics, Inc. (AGLE) | Grant/Award | 43,000 | n/a |
| Jun 10, 2021 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 23,500 | n/a |
| Jun 9, 2021 | Aeglea BioTherapeutics, Inc. (AGLE) | Grant/Award | 40,000 | n/a |